We are committed to saving and improving lives by unlocking the power of the immune system
We are focused on the research, development and manufacturing of innovative life-saving vaccines
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
The 2023 Annual General Meeting was held on Thursday, March 30, 2023.